Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 14, 2009

Nacalai Gains Distribution Rights to  LifeSensors’ Products in Asian Market

  • Nacalai USA entered into a distribution agreement with LifeSensors related to the latter’s Ubiquitin Proteasome Pathway (UPP) research tools and recombinant protein-expression technologies in Japan, Singapore, South Korea, and Taiwan.

    San Diego-based Nacalai USA and its parent company Nacalai Tesque, a Japanese life science research reagent and chemical company headquartered in Kyoto, will facilitate distribution in these regions.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »